exendin

You have access
Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
Olof Eriksson, Irina Velikyan, Torsten Haack, Martin Bossart, Iina Laitinen, Philip J. Larsen, Jan Erik Berglund, Gunnar Antoni, Lars Johansson, Stefan Pierrou, Joachim Tillner and Michael Wagner

Journal of Nuclear Medicine May 1, 2022, 63 (5) 794-800; DOI: https://doi.org/10.2967/jnumed.121.262506
Open Access
Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
Marti Boss, Desiree Bos, Cathelijne Frielink, Gerwin Sandker, Patricia Bronkhorst, Sanne A.M. van Lith, Maarten Brom, Mijke Buitinga and Martin Gotthardt

Journal of Nuclear Medicine November 1, 2020, 61 (11) 1588-1593; DOI: https://doi.org/10.2967/jnumed.119.238998
Open Access
Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
Marti Boss, Desiree Bos, Cathelijne Frielink, Gerwin Sandker, Selen Ekim, Camille Marciniak, Francois Pattou, Go van Dam, Sanne van Lith, Maarten Brom, Martin Gotthardt and Mijke Buitinga

Journal of Nuclear Medicine July 1, 2020, 61 (7) 1066-1071; DOI: https://doi.org/10.2967/jnumed.119.234542
You have access
Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes
Eshita Khera, Liang Zhang, Sheryl Roberts, Ian Nessler, Darleen Sandoval, Thomas Reiner and Greg M. Thurber

Journal of Nuclear Medicine November 1, 2019, 60 (11) 1635-1641; DOI: https://doi.org/10.2967/jnumed.118.224881

Main menu

User menu

Search

exendin